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Abstract
Background: We investigated the feasibility and appropriateness of enrolling controls for Burkitt lymphoma (BL)
from local health facilities in two regions in Uganda.
Methods: BL case data were compiled from two local hospitals with capacity to diagnose and treat BL in North-
west and North-central regions of Uganda during 1997 to 2009. Local health facility data were compiled from
children attending four representative local health facilities in the two regions over a two week period in May/June
2010. Age and sex patterns of BL cases and children at local facilities were compared and contrasted using
frequency tables.
Results: There were 999 BL cases diagnosed in the study area (92% of all BL cases treated at the hospitals): 64%
were from North-central and 36% from North-west region. The mean age of BL cases was 7.0 years (standard
deviation [SD] 3.0). Boys were younger than girls (6.6 years versus 7.2 years, P = 0.004) and cases from North-central
region were younger than cases from North-west region (6.8 years versus 7.3 years, P = 0.014). There were 1012
children recorded at the four local health facilities: 91% at facilities in North-central region and 9% from facilities in
North-west region. Daily attendance varied between 1 to 75 children per day. The mean age of children at health
facilities was 2.2 years (SD 2.8); it did not differ by sex. Children at North-central region facilities were younger than
children at North-west region facilities (1.8 years versus 6.6 years, P < 0.001).
Conclusions: While many children attend local health facilities, confirming feasibility of obtaining controls, their
mean age is much lower than BL cases. Health facilities may be suitable for obtaining young, but not older,
controls.
Background
Infection with Epstein-Barr virus (EBV) [1-3] and Plas-
modium falciparum malaria [4-9] have been implicated
in endemic Burkitt lymphoma (BL), a B cell non-Hodg-
kin lymphoma (NHL) described in African children by
Denis Burkitt fifty years ago [10]. Significant associations
between EBV and BL have been reported in case-control
[7,8] and prospective [2] studies, and the EBV can be
detected, as clonal episomes, integrated DNA, or early
EBV Early RNA protein in (95%) of tumors [3]. The
connection between malaria and BL is more tenuous,
based on geographical co-distribution of both conditions
at a population level [4-6]. However, correlation at a
population level may not be true at the individual level
(also called ecological fallacy). Recently, significant asso-
ciation at the individual level between anti-malaria anti-
bodies and BL has been reported case-control studies
[7-9]. However, interpretation of differences in antibody
levels found in a case-control setting is not straightfor-
ward as differences could reflect changes occurring
after, not before, onset of BL- also called reverse causa-
tion bias [11]. Thus, the cause and effect relationship
between malaria and BL remains an important, albeit
unanswered, scientific and public health question [12].
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[13], the link between malaria and BL may be investigated
indirectly by evaluating the association between malaria-
resistance genes and BL. This approach has the merit of
being free from reverse causation bias, and genotypes can
be measured reproducibly. Three small studies [14-16]
attempted to use this approach some 40 years ago by mea-
suring frequency polymorphisms in the ß-globin gene asso-
ciated with the sickle cell trait (HBAS). Significantly or
marginally reduced risk of BL was noted in two studies
[15,16], but not in the third study [14]. Subgroup analysis
of the third study focusing on another haemoglobin variant
known as haemoglobin C (HBAC), which is also linked
with malaria resistance, noted a decreased frequency of
that variant in children with BL. Although our understand-
ing of the role of genes in malaria resistance has increased
vastly since these pioneering studies were conducted, and
includes more than 50 implicated variants in 25 genes, no
studies have investigated the role of these genes in BL.
We are conducting a prospective case-control study of
BL in East Africa entitled “Epidemiology of Burkitt lym-
phoma in East African children and minors” (EMBLEM:
http://emblem.cancer.gov) [17,18] to investigate the asso-
ciation between malaria-resistance genes and BL. The
study is being conducted in rural areas adjacent to rivers
or lakes in northern Uganda, Western Kenya and northern
Tanzania, where environmental exposure to malaria is
intense and continuous for 7-12 months per year [19].
Given the ubiquity of malaria exposure in the region, we
assume that carriage (or not) of malaria-resistance genes
will be one of the main factors influencing lifetime burden
of malaria in children living in the study area. Another
assumption is that children residing in the same geogra-
phical area will have comparable exposure to malaria.
Hence, appropriate controls would have to be matched on
age and geographical area of residence. In this paper, we
investigated whether local health facilities might be an
appropriate source of controls for BL cases by comparing
and contrasting age and sex patterns of children at local
facilities versus those of BL cases diagnosed at two partici-
pating hospitals in the study region in Uganda.
Methods
Ethics statement
Ethical approval to conduct the EMBLEM Study was
obtained from the Uganda National Council of Science
and Technology (Reference number: HS 816) and
National Cancer Institute Special Studies Institutional
Review Board (Reference number 10-C-N133).
Study population: primary study base and strategies to
improve ascertainment
Prior to implementing the EMBLEM study, we con-
ducted an epidemiological study to define the primary
s t u d yb a s e[ 1 8 , 2 0 ]a n dap a t h o l o g ys t u d yt oi n v e s t i g a t e
the quality of BL diagnosis at St. Mary’s Hospital, Lacor
[17]. The epidemiological study revealed that 90% of
cases treated at the hospital resided within a radius of
100 miles of the hospital. Most BL cases presented with
symptoms lasting 4-8 weeks of disease onset [18]. Based
on these findings, we defined the primary study base of
EMBLEM as children residing in a geographical area
within a radius of 100 mile from participating hospitals
for at least 4 months. Only 8 (~3%) of BL patients trea-
ted during 1994 to 1998 at the Uganda Cancer Institute
[8], which is 350 km away in the capital city of Uganda,
were from the EMBLEM study area. This suggests that
BL cases tend to seek care at hospitals near their home.
The pathology study at Lacor revealed that accuracy of
pathology diagnosis although high (82%), it was variable
(58% to 88%) [17]. Thus, the quality of pathology
needed to be improved to obtain a complete and accu-
rate BL case ascertainment from the primary study base.
To improve case ascertainment from the primary
study base, EMBLEM has implemented four basic strate-
g i e s :a )i n t r o d u c e df r e ep r o t o c o l - b a s e dB Lt r e a t m e n ta t
participating hospitals to encourage case referral; b)
introduced free diagnostic services at no cost to the
patient; c) introduced culturally adapted BL education
and awareness messages using illustrated posters http://
emblem.cancer.gov/resources/index.html, animations,
and audio, video, and radio messages targeting the com-
munity; and d) introduced community mobilization and
training of local leaders and community research assis-
tants to inform the community about BL, services,
research, and improve follow up of cases. Together,
these initiatives should improve case ascertainment in
the study area by reducing time to presentation and
boost case detection and referral to participating
hospitals.
Historical BL case distribution
BL data for children aged 0-15 years diagnosed during
1997 and 2009 were compiled from St. Mary’sH o s p i t a l ,
Lacor, (Gulu) in North-central, and Kuluva Hospital
(Arua) in North-west, two hospitals with capacity to
diagnose and treat BL in the region. Age, sex, month
and year of diagnosis and geographical area of residence
(village, parish, sub-county, county, and district) for BL
cases diagnosed at the two hospitals was abstracted and
computerized [18] by research associates.
Children at local health facilities
Data on children attending local health facilities were
compiled over a 10-day period in May/June 2010 from
four representative local health facilities in the
EMBLEM study region. The facilities evaluated repre-
sent the lowest level local health facility in the country,
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serve a population residing in geographical area called a
parish (comprising 3-6 villages or ~1000 to 7000 peo-
ple). They provide basic outpatient services including
immunization. There are no government run clinics at
the village level because those facilities were replaced by
an ambulatory village health worker team [21]. Facilities
that serve higher level administrative areas, such as the
sub-county (3-6 parishes are called HCIII facilities) or
county (3-6 sub-counties, are called HCIV facilities)
were considered, but deemed to be similar to hospitals
and, therefore, unsuitable for EMBLEM needs. For each
child, information on sex, age, village, parish, district,
symptoms, reason for attending was compiled.
Statistical comparisons
Distribution of BL by sex, tumor anatomic site (only
face or head tumors, abdominal tumors with or without
face or head involvement, and others sites, including
unspecified), and age group (0-3, 4-6, 7-9, 10-12, and
13-15 years) were analyzed using frequency tables. Chi-
squared tests were used to test associations between
categorical variables and Student’s t -tests to test the
equality of means for continuous variables. Calendar
year, geographical region, and age were considered to be
important proxies of intrinsica n de x t r i n s i ce x p o s u r e s ,
so these patterns were examined graphically.
Results
Historical BL cases
There were 1088 BL cases diagnosed at the two hospitals;
999 (92%) were from the EMBLEM study region, includ-
ing 64% from North-central and 36% from North-west
region (Table 1). Most (62%) BL cases were male. The
mean age of the cases was 7.0 years (standard deviation
[SD], 3.0). The majority of cases were aged between 3
and 8 years; only 2% of the cases were aged 0 to 2 years
(Figure 1). Slightly over a half of the cases presented with
abdominal tumours, with or without face or head invol-
vement; 37% presented with face or head tumours.
Compared to BL cases from North-central region,
cases from North-west were older (7.3 years versus 6.8
years, P = 0.014). In region-specific analyses, boys were
younger than girls in cases from North-central region
(6.6 years vs. 7.2 years, P = 0.004) and BL cases invol-
v i n gt h ef a c eo rh e a dt u m o r sw e r ey o u n g e ra g et h a n
abdominal tumors (6.1 vs. 7.2 years, P < 0.001). By con-
trast, among the cases from North-central region, the
mean age of BL cases was similar among boys and girls
(7.3 years vs. 7.2 years, P = 0.79) and similar for cases
involving face or head versus abdominal tumors (7.0 vs.
7.4 years, P = 0.28).
The proportion of cases varied by calendar month
(Figure 2) and by district (Figure 3). The number of
cases diagnosed by month peaked during November to
February and during June to August in North-central
region and during March to May and August to
November in the North-west region.
Geographically, 86% of the cases resided in 9 (39%) of
23 districts in the study area. The districts with many
cases tended to be those nearest to the two hospitals,
Table 1 Characteristics of Burkitt lymphoma cases from
Northern Uganda during 1997-2009
North-central
region
North-west
region
Total
Characteristic n % n % N %
Area of residence
Outside study area 59 9 30 8 89 8
Within study area 637 91 362 92 999 92
Sex
Male 433 62 250 60 683 62
Female 263 38 164 40 427 38
Age group, years
0 - 2 8 1 18 5 26 2
3 - 5 255 37 117 29 372 34
6 - 8 261 37 147 37 408 37
9 - 11 111 16 61 15 172 16
12 - 14 61 9 54 14 115 11
Tumour anatomic site
Abdomen (± face) 365 52 198 48 563 51
Face only 238 34 167 40 405 36
Central nervous system 55 8 7 2 62 6
Others 18 3 24 6 42 4
Not recorded 20 3 18 4 38 3
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Figure 1 Age distribution of historical Burkitt lymphoma cases
(1997-2009) from two hospitals in northern Uganda vs.
potential facility-based controls from four local health centres
from the same region.
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Dokolo, and Pader districts, which are near St. Mary’s
Hospital, Lacor, had few cases, whereas districts such as
Lira and Apac, which are far from St. Mary’sH o s p i t a l ,
Lacor, registered many cases.
Attendance at local health facilities
There were 1012 children at the four HCII facilities in
10 days (Table 2). Most (91%) of the children were
found at facilities in North-central region; only 9% were
found at facilities in the North-west region. Daily atten-
dance at HCII facilities varied widely from day to day.
The average was 40-50 (range, 13-75) children per day
at clinics in the North-central region and 2-7 (range,
1-11) at clinics in the North-west region. Attendance
did not differ by gender.
In contrast to BL cases, the average age of children
attending health facilities was 2.2 years (SD, 2.8).
Furthermore, 73% of children at the local clinics were
aged 0 to 2 years; 92% were aged 3-5 years; only 8% of
children were aged 8-14 years. Of interest, children at
facilities in North-central region were younger than chil-
dren at facilities in North-west region (1.8 years versus
6.6 years, P < 0.001).
More than half (56%) of children attending the facil-
ities were clinically diagnosed as having malaria and
c l o s et oo n e - t h i r d( 2 9 % )w e r ed i a g n o s ea sah a v i n g
respiratory tract infection. However, among 405 children
suspected to have malaria who were tested by blood
microscopy, malaria was confirmed in only 203 (50%).
Confirmed malaria was more frequent in children
aged 0-2 years than older children (29.1% versus 20.4%;
P = 0.004).
Discussion
Using historical BL data to guide our selection of con-
trols by age and geography, we found that many chil-
dren attend local health facilities suggesting that it may
Figure 2 Distribution of Burkitt lymphoma cases in northern
Uganda by district and hospital where they were admitted
(1997-2009).
Figure 3 Distribution of Burkitt lymphoma cases by calendar
month and hospital (1997-2009).
Table 2 Characteristics of children attending four
representative local health facilities in Northern Uganda
in May/June 2010
North-central North-west Total
Characteristic n % n % N %
Sex
Male 488 53 39 44 527 52
Female 436 47 49 56 485 48
Age Group, Years
0 - 2 716 79 7 8 723 73
3 - 5 158 17 31 35 189 19
6 - 8 21 2 25 28 46 5
9 - 11 8 1 15 17 23 2
12 - 14 5 1 10 11 15 1
Reasons for attending facility
Malaria 521 55 56 64 577 56
Respiratory tract infection 291 31 12 14 303 29
Urinary tract infection 16 2 0 0 16 2
Gastroenteritis 54 6 5 6 59 6
Skin 36 4 2 2 38 4
Other 22 2 13 15 35 3
Not recorded 2 0.2 0 2 0.2
Blood test for malaria done
Yes 399 77 6 11 405 70
No 122 23 50 89 172 30
Malaria smear results
Positive 197 49 6 100 203 50
Negative 202 51 0 0 202 50
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However, substantial differ e n c ei nt h em e a na g eo fB L
cases versus the mean age of children found at local
health facilities was observed. Specifically, 92% of chil-
dren at local health facilities were aged 0-5 years. This
percentage is 2.4 times higher than the proportion of
children aged 0-5 years in the general population in
Uganda [22] and 2.6 times higher than children with
historical BL in this region [23]. Based on these differ-
ences in age pattern, local health facilities may be appro-
priate sites for recruiting controls for young BL cases,
but they may not be appropriate sites for recruiting con-
trols for older BL cases. Theoretically, one could enrol
older controls at local health facilities by prolonging the
period of enrolment at the facilities, but such a plan
requires one to assume that the few older children who
are found at local health facilities during the extended
period of enrollment are representative of older children
in the general population. Because EMBLEM is being
conducted in rural areas, we worry that prolongation of
enrollment would lead to a “Hawthorne bias” [24,25]. A
Hawthorne bias occurs when subjects modify behavior
because of actions by the investigator.
Our study also noted that malaria, which is a central
exposure under investigation, is highly prevalent in chil-
dren attending health facilities, especially young chil-
dren. Given the absence of reliable data on malaria
prevalence in children at health facilities versus in the
general population, the high prevalence of malaria in
children at local health facilities is a concern. Alternative
methods of sampling controls were considered. We con-
sidered school-based controls, but rejected them because
children in Uganda start attending school at age 7 years,
thus pre-school children would be excluded. We consid-
ered using other cancers as controls, similar to previous
case-control studies of BL in Africa [7-9,26], but this
idea is not feasible in the EMBLEM study area because
other cancers are rare and not well diagnosed. We con-
sidered hospital controls, but rejected this idea after
reviewing the hospital admissions charts and finding
that hospital controls were much younger (mean age, 2
years) than BL cases, and come from villages near the
hospital than did children with BL. Finally, we consid-
ered neighbourhood controls, as has been used in pre-
vious studies [9,26]. We were concern about
overmatching and lack of mechanism to verify compli-
ance with selection procedures during implementation.
Given these results, the study design was refined to
obtain population-based controls sampled directly from
their homes in the village. For practical reasons, the
controls will be obtained from representative 100 vil-
lages randomly selected from all villages in the study
region. The villages were selected after stratifying by
proximity to water defined as village having a boundary
within or ≥ 500 m of a swamp, river, or lake, and by
rural and urban status, defined according to population
density from the national census [22]. Stratification was
necessary because malaria transmission and BL risk cor-
related with proximity to water and urban status
[27,28]. Children in households selected randomly from
a household list are approached and matched according
to a pre-specified age and sex eligibility criteria will be
invited to participate in EMBLEM as controls.
Our current study does not conclusively evaluate the
validity of population versus facility-based controls.
Thus, we included a pilot component where both popu-
lation and facility-based controls will be obtained in 12
villages to examine this issue. Specifically, population
pilot controls (PPC) selected from the village (90 per vil-
lage) will be compared to health centre pilot controls
(HCPC) enrolled at the HCII (30 per health facility ser-
ving the village). These controls will be compared for
distribution of asymptomatic, mild malaria, and malaria-
resistance genotypes to determine whether one group is
invalid and, if so, to what extent.
To conclude, we compared and contrasted age and sex
patterns of historical BL patterns with patterns of chil-
dren attending local health facilities to gain insights
about feasibility and appropriateness of local facilities as
site to enrol controls for BL. We noted substantial dif-
ferences in the age distribution of BL cases versus chil-
dren at local health facilities leading us to conclude that
local health facilities might not be suitable for enrolling
controls for older BL cases. To address this concern, the
study design was refined to use population-based con-
trols from representative number of villages. A pilot
component was included to investigate bias that may be
related to using different controls.
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